Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Zyban as an Effective Smoking Cessation Aid for Patients Following an Acute Coronary Syndrome: The ZESCA Trial

NCT00689611 is registered in ClinicalTrials.gov with Mark Eisenberg as lead sponsor.

NCT NCT00689611
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00689611 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Zyban as an Effective Smoking Cessation Aid for Patients Following an Acute Coronary Syndrome: The ZESCA Trial
Lead sponsor
Mark Eisenberg
Phase
Phase 3
Overall status
Completed
Start date
December 31, 2005
Completion date
June 30, 2010
Enrollment
392 (actual)
Sites
38

Conditions

As the registry lists them; a condition with its own page is linked.

acute coronary syndrome, myocardial infarction, smoking